Effect of supplementation in treatment of patients with gestational diabetes

Phase 3

Conditions: Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
O24.9

Registration Number: IRCT201601035623N63

Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Pregnant women aged 18-40 years
Diagnosed with GDM at weeks 24-28 of gestation

Exclusion Criteria

Women with preterm premature rupture of membranes
Placental abruption
Preeclampsia
Eclampsia
Hypo or hyperthyroidism
A history of T2DM
A family history of GDM
Smokers
Kidney or liver disease
Taking probiotics, antibiotics or glucocorticoids
Requiring insulin therapy

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Fasting blood sugar. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.

Secondary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;VLDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;LDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.